Health
Investigational Alzheimer’s drug reduces molecular markers of the disease – News-Medical.Net
An investigational Alzheimer’s drug reduced molecular markers of disease and curbed neurodegeneration in the brain, without demonstrating…
An investigational Alzheimer’s drug reduced molecular markers of disease and curbed neurodegeneration in the brain, without demonstrating evidence of cognitive benefit, in a phase 2/3 clinical trial led by researchers at Washington University School of…
Continue Reading
-
General21 hours agoOf saints and sinners | The Spectator Australia
-
General22 hours agoWhy the nation needs the Nationals to ditch Net Zero
-
General21 hours agoChina and Philippines trade blame over latest South China Sea clash
-
General22 hours agoSmall plane crashes into San Diego neighbourhood, setting homes and vehicles on fire